1800-272-662
Shopping Cart 0
countryflagAU
Login

Uscom Ltd

Healthcare AU UCM

0.012AUD
-(-%)

Last update at 2026-03-11T23:00:00Z

Day Range

0.010.01
LowHigh

52 Week Range

0.010.03
LowHigh

Fundamentals

  • Previous Close 0.01
  • Market Cap3.12M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.86646M
  • Revenue TTM2.41M
  • Revenue Per Share TTM0.01
  • Gross Profit TTM 2.06M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -3.25168M -2.02732M -2.55663M -1.93987M -0.88220M
Minority interest - - - - -
Net income -3.30276M -2.07475M -2.59089M -1.97231M -0.92424M
Selling general administrative 4.83M 3.69M 3.44M 4.85M 2.74M
Selling and marketing expenses 1.09M 1.07M 0.95M 0.66M 0.63M
Gross profit 2.23M 3.12M 2.25M 2.91M 3.37M
Reconciled depreciation - 0.39M 0.38M 0.42M 0.40M
Ebit -3.19933M -1.89580M -2.45371M -2.35552M -0.78669M
Ebitda -3.05580M -1.50931M -2.07104M -1.93987M -0.39044M
Depreciation and amortization 0.14M 0.39M 0.38M 0.42M 0.40M
Non operating income net other - - - - -
Operating income -3.72940M -2.37597M -2.45371M -2.35552M -0.78669M
Other operating expenses 6.31M 6.13M 5.58M 5.19M 5.29M
Interest expense 0.13M 0.13M 0.10M 0.08M 0.10M
Tax provision 0.05M 0.05M 0.03M 0.03M 0.04M
Interest income 0.09M 0.05M 0.13M 0.04M 0.03M
Net interest income - -0.08548M -0.04753M -0.05531M -0.06377M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.05M 0.05M 0.03M 0.03M 0.04M
Total revenue 2.58M 3.73M 2.66M 3.25M 3.86M
Total operating expenses 5.96M 5.52M 5.16M 4.85M 4.81M
Cost of revenue 0.35M 0.61M 0.42M 0.34M 0.49M
Total other income expense net 0.48M 0.35M 0.41M 0.42M -0.09551M
Discontinued operations - - - - -
Net income from continuing ops - -2.07475M -2.59089M -1.97231M -0.92424M
Net income applicable to common shares -3.30276M -2.07475M -2.59089M -1.97231M -0.92424M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 3.25M 5.13M 5.18M 7.99M 5.33M
Intangible assets 0.00587M - 0.50M 0.48M 0.47M
Earning assets - - - - -
Other current assets 0.66M - 0.00000M 0.40M 0.44M
Total liab 3.29M 2.07M 2.14M 2.06M 2.26M
Total stockholder equity -0.03822M 3.06M 3.04M 5.94M 3.08M
Deferred long term liab - - - - -
Other current liab 0.69M 0.68M -0.00000M 0.20M 0.62M
Common stock 40.44M 40.42M 38.51M 39.14M 34.67M
Capital stock - - 38.51M 39.14M 34.67M
Retained earnings -44.88108M -41.57832M -39.50357M -36.91268M -34.94037M
Other liab - - 0.09M 0.07M 0.07M
Good will - - - - -
Other assets - 0.00000M 0.08M 0.08M 0.08M
Cash 0.97M 1.05M 2.18M 4.70M 1.71M
Cash and equivalents - - 0.30M 3.02M 0.02M
Total current liabilities 2.79M 1.28M 1.21M 0.90M 0.95M
Current deferred revenue - - 0.67M - -
Net debt 1.30M -0.05776M -1.08715M -3.39213M -0.28062M
Short term debt 1.90M 0.30M 0.26M 0.22M 0.19M
Short long term debt - - - - -
Short long term debt total 2.26M 0.99M 1.09M 1.31M 1.43M
Other stockholder equity - 0.00000M 0.10M 3.71M 3.35M
Property plant equipment - - 0.86M 1.12M 1.33M
Total current assets 2.65M 3.87M 3.74M 6.31M 3.45M
Long term investments - - - - -
Net tangible assets - - 2.53M 5.45M 2.61M
Short term investments - 1.47M - - -
Net receivables 0.22M 0.72M 0.37M 0.34M 0.40M
Long term debt - - - - -
Inventory 0.80M 0.62M 0.75M 0.87M 0.89M
Accounts payable 0.20M 0.30M 0.28M 0.48M 0.14M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 4.41M 4.22M 4.04M 3.71M 3.35M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.42M 0.08M 0.08M 0.08M
Deferred long term asset charges - - - - -
Non current assets total 0.60M 1.27M 1.44M 1.68M 1.88M
Capital lease obligations - - 1.09M 1.31M 1.43M
Long term debt total - - 0.83M 1.09M 1.24M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -0.05755M -0.15194M -0.11531M -0.03335M
Change to liabilities - - 0.47M -0.01952M 0.03M
Total cashflows from investing activities -0.06878M -0.05755M -0.15194M -0.11531M -0.03335M
Net borrowings - - -0.31043M -0.25531M -0.27100M
Total cash from financing activities 1.21M 1.57M -0.95296M 4.05M -0.28187M
Change to operating activities - - -0.11402M 0.06M -0.01512M
Net income -3.30276M -2.07475M -2.59089M -1.97231M -0.92424M
Change in cash -1.55325M 0.34M -2.52544M 2.99M -0.21010M
Begin period cash flow 2.52M 2.18M 4.70M 1.71M 1.92M
End period cash flow 0.97M 2.52M 2.18M 4.70M 1.71M
Total cash from operating activities -2.70997M -1.16339M -1.42402M -1.55666M 0.05M
Issuance of capital stock - 2.00M - 4.36M -
Depreciation 0.39M 0.39M 0.36M 0.42M 0.40M
Other cashflows from investing activities -0.05454M -0.04968M - - -
Dividends paid - - - - -
Change to inventory -0.18085M 0.13M 0.12M 0.02M -0.06603M
Change to account receivables 0.02M 0.06M -0.02738M 0.00438M 0.05M
Sale purchase of stock 0.00000M -0.08600M -0.64253M -0.05486M -0.01087M
Other cashflows from financing activities 1.57M -1.53609M -0.31043M -0.25531M -0.27100M
Change to netincome - - 0.34M 0.53M 0.58M
Capital expenditures 0.01M 0.06M 0.15M 0.12M 0.03M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.19139M 0.38M 0.44M 0.71M 0.73M
Stock based compensation 0.17M 0.23M - - -
Other non cash items 0.22M -0.09016M - 1.56M 0.53M
Free cash flow -2.72421M -1.22094M -1.57596M -1.67197M 0.02M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
UCM
Uscom Ltd		 - -% 0.01 - - 1.29 2.16 1.71 -2.7179
COH
Cochlear Ltd		 -4.74 2.65% 174.42 33.10 26.39 4.88 6.04 5.59 23.13
4DX
4DMEDICAL Ltd		 -0.15 3.55% 4.07 - - 401.92 37.59 417.71 -7.2899
AVR
Anteris Technologies Global Corp		 - -% 9.10 - - 475.96 166.77 334.65 -5.1986
PNV
Polynovo Ltd		 - -% 0.94 94.00 30.21 4.66 7.81 4.68 93.96

Reports Covered

Stock Research & News

View All

Profile

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm. The company also provides the SpiroSonic Ultrasonic spirometer, a pulmonary function testing device that uses multi-path ultrasound; SpiroSonic FLO and SpiroSonic AIR, a digital multi-path ultrasonic spirometer for pulmonary function diagnostic and monitoring COPD and asthma; and SpiroSonic SMART for use by general practitioners and patients for screening COPD and asthma. It serves hospitals and medical care locations through its distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia.

Uscom Ltd

66 Clarence Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Dr. Robert Allan Phillips DMU, Ph.D.(Med), AMS, MPhil (Med), FASE, FIR Founder, Exec. Chairman, CEO & Chief Scientist 1953
Mr. Brett Thomas Crowley B.Com., BCom, C.A., CA, DipLaw Company Sec. & Non-Exec. Director 1957
Mr. Nicholas Schicht Gen. Mang. 1966
Dr. Robert Allan Phillips AMS, DMU, FASE, FIR, MPhil (Med), Ph.D.(Med) Founder, Executive Chairman, CEO & Chief Scientist 1953
Mr. Brett Thomas Crowley B.Com., BCom, C.A., CA, DipLaw Company Secretary & Non-Executive Director 1957
Mr. Nicholas Schicht General Manager 1966
Dr. Robert Allan Phillips AMS, DMU, FASE, FIR, MPhil (Med), Ph.D.(Med) Founder, Executive Chairman, CEO & Chief Scientist 1953
Mr. Brett Thomas Crowley B.Com., BCom, C.A., CA, DipLaw Company Secretary & Non-Executive Director 1957
Mr. Nicholas Schicht General Manager 1966
Dr. Robert Allan Phillips AMS, DMU, FASE, FIR, MPhil (Med), Ph.D.(Med) Founder, Executive Chairman, CEO & Chief Scientist 1953

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.